Clinical trial

Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes

NCT00572689

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Exenatide Normalized identity: exenatideView linked drug · Find medicine records · Find other trials using this name

GENETIC · Unmapped registry intervention Buccal/blood Sample Collection Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2013-08-01

PhasePHASE4

Conditions

Gestational Diabetesverified · MONDO: gestational diabetes

Interventions

ExenatideDRUG · verified · RxNorm: exenatide

Buccal/blood Sample CollectionGENETIC

Sponsors & collaborators

Georgetown Universitylead sponsor

Medstar Health Research Institutecollaborator

Mapped research locations

Washington D.C.District of Columbia, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00572689 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.